Liquid compositions comprising valsartan

Details for Australian Patent Application No. 2008321159 (hide)

Owner Novartis AG

Inventors Talamonti, Wayne; Wagner, Robert Frank; Zielinski, Joseph Lawrence; Harasymiw, Gregory

Agent Davies Collison Cave

Pub. Number AU-A-2008321159

PCT Pub. Number WO2009/064681

Priority 60/987,178 12.11.07 US

Filing date 10 November 2008

Wipo publication date 22 May 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/064681 Priority application(s): WO2009/064681

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008321161-Method and system for connecting solar cells or slices in a panel system

2008321156-Preamble design for a wireless signal